GGrantIndex
← Leaderboards

Andrew Robert Judge

University Of Florida

$8,002,138
Attributed
$10,520,328
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,520,328 · 10

By mechanism

R01$6,007,028 · 2
R44$1,987,656 · 1
U54$1,170,000 · 1
P50$746,384 · 3
R21$358,875 · 1
R03$215,385 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Muscle

Research focus

MuscleMuscular AtrophyMuscle FormSkeletal Muscle WastingAtrophicProteinsProgramsMalignant NeoplasmsMediatingPathway InteractionsResponseSkeletal MuscleMuscle FibersStructurePreventClinical ResearchBaseAffectPhysical FunctionCancer PatientCancer CachexiaQuality Of LifeTumorMuscle Cells

Grant awards (35)

The Complement System and Cancer Cachexia$439,073
R01 · FY2025 · AR · contact PI
Training Core - Judge_Crosbie(UCLA)$116,259
P50 · FY2025 · HD · contact PI
2025 Cancer Cachexia Conference: Cachexia management today and potential treatments for tomorrow$35,000
R13 · FY2025 · CA · contact PI
Development of novel therapeutics for cancer cachexia$997,245
R44 · FY2024 · CA
The Complement System and Cancer Cachexia$462,810
R01 · FY2024 · AR · contact PI
Core B - Training Core$154,250
P50 · FY2024 · AR · contact PI
Development of novel therapeutics for cancer cachexia$990,411
R44 · FY2023 · CA
The Complement System and Cancer Cachexia$477,124
R01 · FY2023 · AR · contact PI
Core B - Training Core$154,250
P50 · FY2023 · AR · contact PI
The Complement System and Cancer Cachexia$477,124
R01 · FY2022 · AR · contact PI
Core B - Training Core$154,250
P50 · FY2022 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$412,725
R01 · FY2021 · AR · contact PI
Core B - Training Core$167,375
P50 · FY2021 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$18,806
R01 · FY2021 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$647,986
R01 · FY2020 · AR · contact PI
Admin Supplement FoxO signaling and skeletal muscle atrophy$228,753
R01 · FY2020 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$414,489
R01 · FY2019 · AR · contact PI
Core B: Training Core$229,000
U54 · FY2019 · AR · contact PI
Diversity Supplement for Enrique Trevino$18,806
R01 · FY2019 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$413,043
R01 · FY2018 · AR · contact PI
Core B: Training Core$229,000
U54 · FY2018 · AR · contact PI
FoxO signaling and skeletal muscle atrophy$397,595
R01 · FY2017 · AR · contact PI
Core B: Training Core$229,000
U54 · FY2017 · AR · contact PI
Core B: Training Core$229,000
U54 · FY2016 · AR · contact PI
Dysregulation of sarcomere stabilizing proteins cause muscle atrophy and weakness during cancer cachexia$163,125
R21 · FY2016 · CA · contact PI
FOXO signaling and skeletal muscle atrophy$322,689
R01 · FY2015 · AR · contact PI
Core B: Training Core$254,000
U54 · FY2015 · AR · contact PI
Dysregulation of sarcomere stabilizing proteins cause muscle atrophy and weakness during cancer cachexia$195,750
R21 · FY2015 · CA · contact PI
FOXO signaling and skeletal muscle atrophy$317,121
R01 · FY2014 · AR · contact PI
FOXO signaling and skeletal muscle atrophy$308,161
R01 · FY2013 · AR · contact PI
FOXO signaling and skeletal muscle atrophy$325,064
R01 · FY2012 · AR · contact PI
FOXO signaling and skeletal muscle atrophy$325,659
R01 · FY2011 · AR · contact PI
Heat shock proteins and disuse muscle atrophy$69,617
R03 · FY2011 · AR · contact PI
Heat shock proteins and disuse muscle atrophy$72,518
R03 · FY2010 · AR · contact PI
Heat shock proteins and disuse muscle atrophy$73,250
R03 · FY2009 · AR · contact PI